Android app Apple app link

The Chemours Company (CC) Analyst Forecast

NYSE Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$15.48
Day's range
$17.45

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
05/11/2026 Morgan Stanley Vincent Andrews $21.00 $24.45   -14.11%
05/06/2026 Mizuho Securities John Roberts $30.00 $27.93   7.41%
04/28/2026 Truist Financial Peter Osterland $30.00 $26.48   13.29%
04/10/2026 RBC Capital Arun Viswanathan $26.00 $22.86   13.74%
02/23/2026 Jefferies Laurence Alexander $17.00 $18.16   -6.36%
02/23/2026 Morgan Stanley Vincent Andrews $17.00 $17.04   -0.23%
01/19/2026 BMO Capital John McNulty $20.00 $15.61   28.12%
11/10/2025 Truist Financial Peter Osterland $18.00 $12.90   39.53%
10/16/2025 Mizuho Securities John Roberts $18.00 $14.42   24.83%
10/06/2025 UBS Joshua Spector $21.00 $15.94   31.74%
09/23/2025 Mizuho Securities John Roberts $19.00 $17.02   11.63%
05/07/2025 UBS Joshua Spector $17.00 $12.10   40.5%
04/15/2025 Mizuho Securities John Roberts $15.00 $11.28   32.98%
10/11/2024 RBC Capital Arun Viswanathan $28.00 $19.78   41.56%
10/07/2024 BMO Capital John McNulty $32.00 $19.57   63.52%
08/06/2024 BMO Capital John McNulty $30.00 $18.77   59.83%
06/07/2024 Mizuho Securities John Roberts $25.00 $23.90   4.6%
05/29/2024 UBS Rich Hilliker $31.00 $26.65   16.32%
04/09/2024 BMO Capital John McNulty $34.00 $27.05   25.69%
04/01/2024 UBS Joshua Spector $28.00 $28.74   -2.57%
04/01/2024 CFRA Emily Nassedd Mitsch $18.00 $28.74   -37.37%
03/13/2024 D.A. Davidson Linda Bolton Weiser $24.00 $26.84   -10.58%
12/01/2023 RBC Capital Arun Viswanathan $40.00 $29.53   35.46%
10/30/2023 Morgan Stanley Vincent Andrews $33.00 $23.58   39.95%
01/10/2023 RBC Capital Arun Viswanathan $33.00 $32.55   1.38%
05/19/2021 Bank of America Securities Matthew DeYoe $42.00 $32.59   28.87%
05/09/2021 Morgan Stanley Vincent Andrews $35.00 $33.08   5.8%
05/05/2021 Argus Research David Coleman $40.00 $33.58   19.12%

Chemours Company FAQ's

Chemours Company has been rated by research analysts at Alembic Global, Morgan Stanley, RBC Capital, UBS, Mizuho Securities, Truist Financial in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.